Popular ASRA Coags app helps physicians protect patients taking anticoagulants

The popular ASRA Coags app has just been updated to combine the latest regional anesthesia/acute pain medicine and chronic pain medicine drugs, procedures, and interventions. ASRA Coags 2.0 has combined the previous ASRA Coags Regional and ASRA Coags Pain apps into one handy tool and is available for iOS and Android devices.

The app has been praised for being thorough and easy to use, and it provides yet another safeguard to double check interactions.

"This app is amazing. My procedure nurses love it as they can cross check any individual procedure with any anticoagulant or antiplatelet medications," tweeted Samer Narouze, MD, PhD, shortly after the app's release. In the first 24 hours, nearly 7,100 people had updated the app.

The basis for the information in ASRA Coags 2.0 are guidelines just published in the American Society of Regional Anesthesia and Pain Medicine's journal Regional Anesthesia and Pain Medicine.

  • Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition)
  • Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition)

ASRA has also released an updated ASRA LAST 2.0 app, based on the ASRA Checklist for Treatment of Local Anesthetic Systemic Toxicity, which provides an algorithm for physicians to manage a local anesthetic systemic toxicity (LAST) event during during administration of local anesthetic. The app could potentially be a life-saver as it walks the practitioner through the steps to rescue a patient experiencing this life-threatening event.

Source: https://www.asra.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Key risk factors influencing mortality rates in chronic pulmonary aspergillosis patients